|
Considering A future Sale, Merger or Recapitalization
of your healthcare business?
Paragon Ventures offers a free, no-obligation and confidential pre-market consultation on the current valuation and strategic options for healthcare business owners. For more information, email us here.
| | |
Paragon Ventures is pleased to present the following acquisition, merger and recapitalization opportunities for your consideration.
For more information and additional listings please login to our website or click contact the advisory team at Paragon Ventures.
| | |
Mental Health Services Provider
ID # 325-04005
| | |
Headquarters in US Midwest region, this behavioral health services provider brings trust and dependability to the community it serves. The Company provides educational, social and emotional support through a variety of mental health programs and services. Working with children, teens, adults, couples and families, the Company helps them to reach their full potential in their home, community and society.
Adult Therapy
Child/adolescent Therapy
Couples/family Therapy
THRIVE Services
| |
FINANCIAL PERFORMANCE
For the trailing twelve months the revenue exceeded $ 7.82MM
The Company generated EBITDA of $1.13 MM
| | |
Tech Driven Medical Supply Provider
ID # MA324-10009
| | |
https://www.paragonventures.com/market-pulse-posts/available-for-acquisition-tech-driven-medical-supply-dme/
This HQAA Accredited and well-established Company based in a mid-Atlantic metro area. Product lines include incontinence, urological, wound care, Women’s Health and other DME products. Drop shipments currently represent 70% of their deliveries.
Payor Mix: Medicaid – 67% Medicare – 24% Other Ins – 8%
This acquisition provides the acquirer access to proprietary tools and systems that can be applied across an expanded healthcare distribution business. Benefits include improving performance, better billing outcomes, fewer compliance risks, and faster resupply turnovers. A buyer acquires not just a business, but a fully equipped technology engine that will generate measurable upside from day one. Resulting in margin improvement, scalability, and operational resilience.
| Well Diversified Product Mix | |
FINANCIAL PERFORMANCE
For FY 2024 the revenue was $10,607,046 with an adjusted EBITDA of $2,383.07. Projected revenue for FY 2025 is $13.5M, with an adjusted EBITDA of $4M.
| | |
Pharmacies in the workers’ compensation space operate within a specialized, regulatory-heavy environment. These businesses serve injured employees whose prescriptions are reimbursed through state-mandated workers’ comp systems, not traditional commercial or Medicare & Medicaid payers. The complexity of navigating various state laws, formularies, and prior authorization rules creates high barriers to entry… but also durable competitive advantages for experienced operators. This Company exhibits these competitive advantages with over a decade of operating experience.
Founded in 2015, this Company has become a regionally recognized specialized pharmacy focused on providing dedicated care through individualized pharmaceuticals for individuals/workers involved in a personal injury.
This full-service, regulatory compliant pharmacy platform offers a wide range of services to maximize patient outcomes, including free home deliveries, no out-of-pocket expenses for workers, automated reporting, and large, growing physician & attorney referral network
| | |
FINANCIAL PERFORMANCE
For the year ended 2024 revenues were $11.67MM generating 74% gross profit. The business generated 51% net ordinary income and adjusted EBITDA exceeding $7MM in 2024. 2025 results are expected to produce revenues in the range of $12.5-13.5MM and generating adjusted EBITDA exceeding $ 8MM.
| | |
Headquartered in the Mountain States this diabetic, retail pharmacy and general store business is well established. The Company provides diabetic products (CGM) and supplies to patients within the state and has strong ties locally for the other business.
Payor Mix
Medicare 10%
Medicaid 70 %
Commercial Insurance 20 %
The company staff includes clinical, operational, and administrative functions with decades of experience. This has enabled the company to expand and grow with the needs of its customers. The Company’s reputation servicing its patients provides strong margins and a sustainable EBITDA.
| |
FINANCIAL PERFORMANCE
For the year ended 2024 the Company generated revenue exceeding $18.8MM and EBITDA of $2.1MM
| | |
The Company has been empowering children to communicate with the world since 1984.
Speech-language pathology is a field services provided by speech therapists or speech-language pathologists (SLP) for treating speech impairment, language, communication, or swallowing problems among individuals. The therapy includes intervention services, focusing on improving a patient’s speech and abilities to understand and express language, including nonverbal language.
This well-established business offers a unique opportunity to acquire a well established and thriving speech therapy(SLP) business. Led by an exemplary clinician management team with over 40 years of experience operates in the MidAtlantic region. The organization includes speech language pathologists who work with school districts, intermediate units and pediatric programs providing therapeutic services to children
| | |
FINANCIAL PERFORMANCE
Revenues exceed $2.5MM with adjusted EBITDA of $790,000
| | HME - Respiratory & Medical Supply | | |
This MidAtlantic medical equipment, supplies and services provider has built a strong contract portfolio with strong payor relationships. The company provides service to patients in their home, skilled nursing facilities, hospitals, and VA facilities. The Company was recently awarded contracts which will continue driving growth in 2026/2027.
Product Mix
DME 38%
Respiratory 16%
Oxygen 18%
Oxy Cylinder 8%
Beds 7%
Lifts 8%
Other 5%
The company has been servicing the HME sectors for over 30 years. The company includes highly trained and experienced healthcare professionals including Registered Nurses and Respiratory Therapists along with dedicated administrative personnel that serve the Company’s growing patient population.
| | |
FINANCIAL PERFORMANCE
Annual Revenue: $ 10 MM - Adjusted EBITDA: $ 1MM
| | Your Referrals Are Valued | | |
Not sure if you are familiar with our Professional Referral Network, PRN program. We do offer a referral fee (minimum $5K) for qualified referrals looking to sell, merge or recapitalize their business that we represent in the process.
Each referred business must be new to Paragon Ventures and :
- In business minimum of 3 years (no startups)
- Generating revenues in excess of ~ $10MM
- Profitability in excess of 10% (minimum net operating income in excess of $1MM annually)
-
Focused in the healthcare and life sciences sectors we market (https://www.paragonventures.com/sectors/)
For More Information
| |
Paragon Ventures Closes Transactions Exceeding $100MM in 1H2025
| | |
Paragon Ventures Healthcare Market Pulse transactions are provided as a matter of public record. These transactions have been compiled from press releases, corporate announcements and other public sources to provide an overview of acquisition and merger activities within healthcare and life sciences sectors.
Click here to view Healthcare Market Pulse Updates
Paragon Ventures tracks completed M&A transactions across the continuum of subacute care. If you are considering a sale, merger or acquisition these transactions can provide some benchmarks for your consideration. For more information on the current M&A market for your healthcare business, click here or call 800-719-1555 for more information.
| | Exploring Options From Strategic Planning To Successful Closing of the Sale | | |
We specialize in the confidential sale of healthcare businesses across the continuum of care
With 250+ yrs of healthcare business ownership, operating and M&A experience the Paragon Ventures team understands the intricacies of the sale process. We know how to highlight the Real Value that business buyers demand. From initial strategic exit planning through valuation and marketing to finalizing the sale, Paragon Ventures manages the entire process.
| | |
We create business opportunities for people
The merger and acquisition business is a “people business” first and foremost. We understand this. The business owners who have worked with us over the past decade can attest to it.
We create business opportunities that deliver REAL VALUE for real people.
| | |
Structuring, negotiating, and closing a deal involves more than mechanics
Our transactions are life-changing for the business owners, their families, and employees. We understand the “psychology of the deal” and the emotions and implications that come with it.
| | |
Our confidential process unlocks the REAL VALUE in your company
Understanding your business and its value… presenting the company in its very best light and finding the opportunities that deliver that REAL VALUE.
This is what we do… every day!
| | |
Professional Advisory Services | |
| | | |
